Skip to main content

Arax Advisory Partners

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1586767 DENVER, CO

Position in ALNY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$4,167,459
+$3,889,860 QoQ
Shares Held
13,844
+1550.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#247
of 764 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 8% Shared 0% None 92%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $59,650,000 across 287 Biotechnology names. ALNY ranks #3 (7.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page
13,844 $4,167,459

All Filings in ALNY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,167,459 13,844
2026-03-31 $277,599 839
2025-12-31 $269,606 678
2025-09-30 $5,966,760 13,085
2025-06-30 $48,913 150
2025-03-31 $22,951 85
2024-12-31 $113,184 481
2024-09-30 $133,389 485
2024-06-30 $116,883 481
2023-12-31 $4,019 21
2023-09-30 $1,416 8
2023-06-30 $569 3
2023-03-31 $1,602 8
2022-12-31 $1,901 8
2022-09-30 $1,601 8